0001595585-19-000253.txt : 20191112
0001595585-19-000253.hdr.sgml : 20191112
20191112185624
ACCESSION NUMBER: 0001595585-19-000253
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191107
FILED AS OF DATE: 20191112
DATE AS OF CHANGE: 20191112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stahl Wilhelm
CENTRAL INDEX KEY: 0001591468
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38558
FILM NUMBER: 191211306
MAIL ADDRESS:
STREET 1: C/O RELYPSA, INC.
STREET 2: 700 SAGINAW DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tricida, Inc.
CENTRAL INDEX KEY: 0001595585
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463372526
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7000 SHORELINE COURT, SUITE 201
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-429-7800
MAIL ADDRESS:
STREET 1: 7000 SHORELINE COURT, SUITE 201
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
wf-form4_157360296866947.xml
FORM 4
X0306
4
2019-11-07
0
0001595585
Tricida, Inc.
TCDA
0001591468
Stahl Wilhelm
7000 SHORELINE COURT, SUITE 201
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Tech Officer & Sr. VP
Common Stock
2019-11-07
4
M
0
2910
1.68
A
17716
D
Common Stock
2019-11-07
4
S
0
2910
39.97
D
14806
D
Employee Stock Option (right to buy)
1.68
2019-11-07
4
M
0
2910
0
D
2027-02-07
Common Stock
2910.0
205042
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.90 to $40.23, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
This option vested 25% on February 1, 2018, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase.
/s/ Edward J. Hejlek, attorney-in-fact
2019-11-12